A monoclonal blocking antibody targeting the glycosylated form PD-L1 in breast cancer cells blocked PD-L1/PD-1 interaction by promoting PD-L1 internalization and degradation 72 therefore inducing a potent tumor cell killing effect. This evidence concerns the gene CD274 and breast carcinoma.